If however you buy directly from the company (in a IPO, or direct
share purchase program of some kind, like ESPP), then it does end up showing in the company account ledgers one way or another.
To name a few, there was the notice that BlackBerry and Cisco signed a broad patent cross-licensing agreement, a new appointee to the Board of Directors, and the announcement of the common
share purchase program.
Employee
Share Purchase Program: Purchase Accenture shares at a 15 % discount to increase your stake in Accenture.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations in ADAP
purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market
share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its
share repurchase
program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
For stockholders of record: The proxy card you received covers the number of
shares to be voted in your account as of the record date, including any
shares held for participants in the IBM Investor Services
Program and Employees Stock
Purchase Plans.
In August 2012, to create incentives for continued long - term success from the then - recently launched Model S
program as well as from Tesla's then - planned Model X and Model 3
programs, and to further align executive compensation with increases in stockholder value, the Board granted to Mr. Musk a stock option award to
purchase 5,274,901
shares of Tesla's common stock (the «2012 CEO Performance Award»), representing 5 % of Tesla's total issued and outstanding
shares at the time of grant.
Shares purchased as part of the
program will be freely tradable and will not be subject to a lock - up agreement.
In March, Qualcomm Inc, under pressure from hedge fund Jana Partners, agreed to boost its
program to
purchase $ 10 billion of its
shares over the next 12 months; the company already had an existing $ 7.8 billion buyback
program and a commitment to return three quarters of its free cash flow to shareholders.
11-18-2005 2005 Drilling
Program Completed on Caledonia's Mulonga Plain Joint Venture 11-14-2005 Caledonia Mining 3rd Quarter Results 2005 10-13-2005 Available online: Webcast of presentation to the Minesite Forum 10-11-2005 London: Presentation to the Minesite Forum 09-14-2005 Caledonia amends terms of
share purchase warrants 09-13-2005 Caledonia and Motapa announce 11 drill targets at Mulonga Plain Kashiji Plain analytical results confirm possible local source 08-15-2005 Caledonia Mining signs a Memorandum of Understanding with a South African Black Economic Empowerment Consortium 08-12-2005 Caledonia Mining Second Quarter Results 2005 08-11-2005 Caledonia Mining Second Quarter Results Conference Call and Webcast 07-18-2005 Caledonia announces Summer Drilling
Program on Kikerk Lake Property, Nunavut 06-22-2005 Caledonia Mining Corporation announces Admission to the AIM Market of the London Stock Exchange and # 1.57 million placing 06-13-2005 Caledonia Mining signs a Letter of Intent with a Cobalt Refinery to supply 3 % of total annual world production 05-16-2005 Caledonia Mining 1st Quarter Results 2005 05-06-2005 Caledonia Annual Meeting set for Tuesday May 10th 2005 05-05-2005 Caledonia Mining Granted Prospecting Right for Grasvally and Will Commence the Drilling
Program by Mid May 2005 03-29-2005 Caledonia Mining 4th Quarter and 2004 Annual Results 03-23-2005 Caledonia Mining Fourth Quarter and Annual results Conference call & webcast 03-08-2005 Mulonga Plain JV Exploration Work
Program Update 02-23-2005 Caledonia Mining Appoints New Chairman 01-31-2005 Caledonia updates diamond exploration results at Mulonga Plain joint venture in Zambia.
It will be completed by the end of March and is part of an ongoing
program to
purchase shares and comes after the completion of the sale of the Las Bambas copper mine in Peru this month, Glencore said.
SMFG issued no new
shares in connection with the listing, but the ADR
program will enable the Japanese bank to respond to merger and acquisition opportunities, such as the
purchase of US banks.
Under this
program, for every
share of Valeant stock that an executive
purchases and commits not to sell for a period covering the executive's upfront equity grant (which is typically three or five years) the Company matches with an RSU that vests over the period covered by the upfront grant, so long as the executive holds the
purchased shares and remains employed by the Company during the vesting period).
With each
purchase of a ShareBar, we will
share one with a child in need served by the Steve's Club National
Program.
Since I am still making my way through the 40 pounds of grass - fed beef I
purchased as part of a cow
share program, I used beef instead of pork in the satay recipe.
Over at USDA Blog, AMS Commodity Procurement
Program Director Dave Tuckwiller blogged about his time at ANC 2014, sharing information on the commodity purchase program with school nutrition profess
Program Director Dave Tuckwiller blogged about his time at ANC 2014,
sharing information on the commodity
purchase program with school nutrition profess
program with school nutrition professionals.
If you participate in the Supplemental Nutrition Assistance
Program (SNAP), you can now use your SNAP benefits to
purchase a CSA
share from Drumlin Farm and earn HIP Rewards!
Business or Tribute Ads You can
purchase an ad for the
program booklet to showcase your company or to
share your support of Five Acres!
Every
purchase you make at Cotton Babies also supports
Share the Love and other
programs to end diaper need.
They can interact on our private community message boards, take advantage of
program pass holder discounts,
share content across a variety of social networks, and even
purchase or renew their
program pass — all right in the palm of their hand.
In his original post on The Daily, David Knowles reported that «USDA... plans to buy 7 million pounds of Lean Beef Trimmings from BPI in the coming months for the national school lunch
program,» and I and other media outlets
shared the same information, i.e., that a
purchase of slime per se was in the works.
Business or Tribute Ads You can
purchase an ad for the
program booklet to showcase your company or to
share your voice in support of Five Acres!
Mr. Scheid said that
program has grown to include five
shared positions: superintendent, assistant superintendent for business, information technology specialist, facilities manager and
purchasing agent.
As with raw milk, this usually must be
purchased directly from a farmer or through a cow -
share program or co-op.
I participate in affiliate marketing
programs where I receive a small commission when products are
purchased through links on my site including Indigo.ca,
Share a Sale and Commission Junction.
It will be certainly be challenging as I continue to work full
purchase phentermine hydrochloride time, complete my Master's
program, and blog — but I'm look forward to
sharing the experience with you!
CNN — Mar 10 — Spark Networks, a provider of online personals services, has established a repurchase
program for the
purchase of up to 1,000,000
shares of Spark Networks Common Stock.
The repurchase
program allows Match Group to buy back 6m
shares of its stock through open market
purchases.
The ways in which you can earn points as part of this
Program will be set forth on the Site, and may include, but not be limited to, making
purchases, signing up for the Site's newsletter, and
sharing certain, specified content via social media (collectively, the «Eligible Activities»).
A unique aspect of our company is that we will offer our customers the opportunity to partner with us in business with the profit
sharing program we have set up, which allows them to make a «percentage of sale» for any referral they bring to us after
purchasing a vehicle.
These
programs let families link Apple or Amazon accounts together to
share information and
purchased content, which will make it harder to switch platforms — now you're not just leaving your own apps behind, but your family members» as well.
Finally, Amazon instituted a new
program that allows you to
share select books you have
purchased from their store with your friends and family with a lending
program.
Offering a premium, ultra-mobile entertainment experience, the Samsung Galaxy Tab 7.0 Plus from T - Mobile comes with a variety of pre-installed premium content, including the Samsung Media Hub so customers can rent or
purchase movies and
purchase TV
programs and
share that content on up to five compatible devices on the same account.
It comes with Samsung Media Hub so that the customers can rent or
purchase movies and
purchase TV
programs and
share that content on up to 5 compatible devices on the same account and haspre - loaded WildTangent app that would let the customers play premium games for free, as well as rent or
purchase games.
-- 4G LTE — 5 to 12 Mbps and upload speeds of 2 to 5 Mbps (in 4G)-- Android 2.2 platform — Adobe ® Flash ® Player compatible — Mobile Hotspot capability —
share 4G connection with up to 10 WiFi - enabled devices or a 3G connection with up to 5 devices — Samsung Media Hub — Samsung's own content service, offering a vast lineup of critically acclaimed films and TV
programs for rent or
purchase — Virtual QWERTY Keyboard featuring Swype Technology
Dividend Re-Investment Plan (DRIP): A
program offered by some corporations (particularly investment companies) in which shareholders may opt to use their dividends to
purchase additional
shares in the corporation in lieu of receiving cash payments.
Parity Parity price Participating preferred stock Participating (semi-fixed) Trusts Partnership Par value Passive income Pass - through security Payment date P / E ratio Penny stocks PHA Bonds Phantom income Pink sheets Placement Ratio Plan completion life insurance PN Point Portfolio income Position limits Positions book Pot Power of attorney Pre-dispute arbitration clause Preemptive right Preferred stock Preliminary prospectus Preliminary study Preliminary statement Premium Pre-refunding Pre-sale order Price to Earnings ratio Primary distribution Primary market Prime rate Principal Principal stockholder Principal transactions Private placement Private placement memorandum Private securities transaction Proceeds sale Production
purchase program Profile Profit - sharing plans Program trading Progressive tax Project note Prospectus Prospectus delivery period Proxy Prudent Man Rule Public float value Public Housing Authority Bonds Public Offering Public offering price Purchaser's representative Put bond Put option Put
program Profile Profit -
sharing plans
Program trading Progressive tax Project note Prospectus Prospectus delivery period Proxy Prudent Man Rule Public float value Public Housing Authority Bonds Public Offering Public offering price Purchaser's representative Put bond Put option Put
Program trading Progressive tax Project note Prospectus Prospectus delivery period Proxy Prudent Man Rule Public float value Public Housing Authority Bonds Public Offering Public offering price Purchaser's representative Put bond Put option Put spread
Also from employee stock
purchase programs that invested an exact number of dollars and bought fractional
shares.
To buy your
shares as cheaply as possible, go through a discount broker or use a direct stock
purchase program, which many companies have.
Just search» (Company Name) direct stock
purchase plan» to see if the
shares you want to buy are available through such a
program.
One of the best employer benefits I ever had was the opportunity to buy discounted
shares of my employer's stock with payroll deductions through an Employee Stock
Purchase Program (ESPP).
Through this
program, credit and financial counseling providers in the US can
share FICO ® Scores they have already
purchased — for example, for initial customer contact or for financial management plan review — with their customers with no additional score fees or
program fees.
The company has not
purchased any
shares under the
program and stated in its 2014 10 - K filing that it has no plans to do so.
Of the stocks Mr. Buffett is investing, I also have
shares in Bank of America and Procter & Gamble,
purchased through DRIP
programs.
The company has authorized a stock repurchase
program that allows for the
purchase of up to 10 % of the company's total outstanding
shares.
The company completed its prior $ 100 million
share repurchase authorization during the quarter and
purchased 650,000
shares under the new
program for $ 14 million and another $ 6.9 million since quarter end.
They're not offered now, but
shared - appreciation
programs might also be available, where investors
share in the appreciation of a home in exchange for assistance at the
purchase, Pickel said.
Stock
purchase plan: a
program that allows investors to
purchase a company's
shares directly, without a brokerage, and often at a discount
While the majority of companies offering DRIP
programs do assess commission fees for
share purchases, a few charge fees that are still far lower than standard brokerage charges.
As a newbie, I still spend a lot of time researching, and in a couple of blogs I have seen references to companies that will provide a small discount on the current stock price when
purchasing additional
shares using their DRIP
program.
Four bank holding companies announced that they had redeemed all of the preferred
shares that they had issued to the U.S. Treasury under the Capital
Purchase Program of the Troubled Asset Relief
Program (TARP).